Caregen (CEO Yongji Jeong), a biotechnology company, announced on the 31st that it successfully completed its exhibition at the AMWC 2025 (Aesthetic & Anti-Aging Medicine World Congress) held at the Grimaldi Forum in Monaco, France as a platinum sponsor.
AMWC 2025 is the world's largest beauty and anti-aging medical academic conference, attended by various experts including global pharmaceutical companies, bio companies, medical device manufacturers, dermatologists, and plastic surgeons. Caregen showcased innovative beauty and anti-aging solutions based on peptides and actively exchanged with medical professionals and industry insiders from around the world. In particular, the Caregen booth attracted the attention of medical professionals and industry insiders from around the world, and continued to receive continuous visits. Experts who directly checked the product paid attention to its technological capabilities and clinical reliability.
On the 27th, an official seminar was held at Room POULENC, where peptide technology that can be applied in various fields such as hair regeneration, weight loss, and muscle strengthening was introduced in depth, drawing great interest from participants.
The flagship product, DR. CYJ Hair Filler, is the world's first scalp-specific filler based on biomimetic peptides, a solution that helps activate scalp cells and improves the hair growth environment. It is already being used in procedures by medical professionals in various countries, and its efficacy was confirmed through clinical effects and real-life cases at this seminar.
In addition, Korglutide has been introduced as an alternative weight loss solution for oral GLP-1-based injections, drawing attention. It suggests the possibility of being a more efficient and sustainable weight management solution due to its high ease of administration, accessibility, and minimal side effects.
Myoki, a peptide based on anti-myostatin for increasing muscle mass and preventing sarcopenia, was introduced as a product that can be widely used in the sports nutrition market as well as in the field of preventing muscle loss due to aging. Experts attending the seminar responded positively to the marketability and scalability of Myoki.
After the seminar, a dinner was held with approximately 50 key global partner companies in attendance, providing a meaningful opportunity to share Caregen's research and development direction and global market strategy and discuss ways to expand cooperation.
A Caregen official said, “AMWC 2025 was an opportunity to once again confirm the global status of Caregen’s peptide technology, and we expect that various cooperation discussions will lead to actual business opportunities,” adding, “We will further strengthen our competitiveness in the bio market through continuous R&D and participation in global exhibitions.”
- See more related articles
You must be logged in to post a comment.